600 patients66,869 observations120 daysLIVE

Patient P-01872

Synthetic patientNBL-101 · Day 104 · 45–54 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Stable
GI state
Unstable
Inflammatory state
Improving
Nutritional resilience
Unstable
Discontinuation risk
91%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 31 NP-02 recommendedDietary Support Protocol NP-02
  3. Day 32 Patient acceptedStarted NP-02 in the companion
  4. Day 42 GI symptom burden −14% vs expectedDietary Support Protocol NP-02
  5. Day 48 Trajectory diverged from predictionObserved response fell below the model's expected path.
  6. Day 48 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 48.

Primary contributors, last 14 days
  • Inflammatory activity-6
  • Treatment adherence+3

What helped?

  • Dietary Support Protocol NP-02Day 31
    Result: symptom burden −14%
LIFE OS recommendation
GI Support Protocol GI-04
92%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
64.4/100
stable · -0.7 vs previous 14 d
Toxicity
Blood
46.1/100
worsening · +3.2 vs previous 14 d
Sleep quality
Wearable
15.6/100
stable · +0.5 vs previous 14 d
Energy level
Daily log
1.8/10
worsening · -0.4 vs previous 14 d
Stress level
Daily log
8.2/10
stable · +0.2 vs previous 14 d
Steps
Wearable
6,065
improving · +240 vs previous 14 d
Adherence
Companion
49.8 %
stable · +0.2 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 28 from the failing basin, 64 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 97%
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 79%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 79%
Would not help
  • Keep fat low
    GI +5.1 next day on high-intake days · n 28
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +5.1detractor · 95%
  • Spicy / capsaicin
    +1.6no signal · 33%
  • Histamine load
    +1.4no signal · 27%
  • Insoluble fibre
    -1.2no signal · 31%
  • Simple carbohydrates
    +0.7no signal · 15%
  • Alcohol
    -0.7no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 85
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 53
    • WearableHRV 23 ms, trending down
  • Butyrate / short-chain fatty acid production 80
    • MicrobiomeButyrate capacity 35/100
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Mucosal barrier integrity 60
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 64 and rising
    • WearableSleep 5.6 h, below personal baseline
  • Autonomic recovery 45
    • WearableResting HR 75 bpm
    • WearableShort sleep window
  • Drug metabolism and exposure 20
    • BloodToxicity index 46
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Rapid metabolizer
    Expected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 35/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
20 ms
Sleep
5.8 h
Steps
5,555
Resting HR
74 bpm
Daily log: GI score 64, nutritional resilience 34, adherence 50.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0181345%S01NP-02no change40
P-0132744%S01GI-04improved56
P-0168837%S01GI-04improved40
P-0131033%S0157
P-0187728%S01CR-01improved67
P-0182121%S0158
P-0182321%S0157
P-0160420%S0171
P-0184620%S0137
P-0163538%S02GI-04improved49
P-0145237%S02GI-04improved46
P-0145929%S0251